Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called up; record profit for Telecom Plus

Tue, 27th Jun 2023 07:56

(Alliance News) - Stock prices in London were set to open higher on Tuesday, following a positive session for equities in Hong Kong and Shanghai.

China is on course to achieve its 5% target for economic growth in 2023 set by Beijing earlier this year, Premier Li Qiang said Tuesday.

"For the whole year, we are expected to achieve the target of about five percent economic growth set at the beginning of this year," Li said as he opened a meeting of global political and business leaders in northern China.

Markets in Europe were beginning to settle following an aborted uprising against President Vladimir Putin in Russia over the weekend, which had put investors in a risk-off mood.

In early UK corporate news, JD Sports Fashion maintained its full-year profit guidance following positive trading in May, and Telecom Plus boasted of a record year of revenue and profitability.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 37.02 points, or 0.5%, at 7,490.60

----------

Hang Seng: up 2.2% at 19,201.58

Nikkei 225: closed down 0.5% at 32,538.33

S&P/ASX 200: closed up 0.6% at 7,118.20

----------

DJIA: closed down just 12.72 points at 33,714.71

S&P 500: closed down 0.5% at 4,328.82

Nasdaq Composite: closed down 1.2% at 13,335.78

----------

EUR: higher at USD1.0929 (USD1.0913)

GBP: higher at USD1.2746 (USD1.2719)

USD: unchanged at JPY143.53 (JPY143.52)

Gold: flat at USD1,926.40 per ounce (USD1,926.27)

(Brent): higher at USD74.80 a barrel (USD74.12)

(changes since previous London equities close)

----------

ECONOMICS

----------

Tuesday's key economic events still to come:

09:00 EDT US house price index

10:00 EDT US Richmond Fed business activity survey

10:00 EDT US consumer confidence survey

16:30 EDT US API weekly statistical bulletin

----------

Chinese Premier Li Qiang slammed efforts in the West to "de-risk" their economies as a "false proposition" on Tuesday, hitting back against US and EU policy aimed at reducing their reliance on China. The US and the EU have in recent months moved to "de-risk" from the world's second-largest economy. "In the West, some people are hyping up what is called 'cutting reliance and de-risking'," Li told delegates at the opening of a World Economic Forum meeting in northern China. "These two concepts...are a false proposition, because the development of economic globalisation is such that the world economy has become a common entity in which you and I are both intermingled," he said in a wide-ranging speech calling for deepening economic globalisation and cooperation.

----------

US President Joe Biden has insisted neither the US nor Nato played any role in the turmoil in Russia. A powerful mercenary group engaging in a short-lived clash with Russia's military at the moment Ukraine is trying to gain momentum would seem like something for the US to embrace, but the public response by Washington has been decidedly cautious. Officials have insisted this was an internal matter for Russia and declined to comment on whether it could affect the war in Ukraine as they look to avoid creating an opening for Russian President Vladimir Putin to seize on the rhetoric of American officials and rally Russians by blaming his Western adversaries.

----------

BROKER RATING CHANGES

----------

UBS cuts BT Group to 'sell' (neutral) - price target 120 (146) pence

----------

HSBC starts Smiths Group with 'hold' - price target 1,860 pence

----------

Berenberg reinitiates Informa with 'buy' - price target 820 pence

----------

COMPANIES - FTSE 100

----------

HSBC will switch global headquarters to London's traditional City finance district, from its current Canary Wharf base in the east of the capital, it said on Monday. The Asia-focused bank, which has encouraged hybrid working since the Covid pandemic, announced in a memo to staff that it will switch to a smaller property near St Paul's Cathedral at the end of 2026. "We have a preferred option – Panorama St Paul's, in the City of London," the memo read. "We will now begin more detailed discussions on a potential lease, with the intention to move in late 2026." The development, which is currently under construction, is on the site of the former headquarters of telecommunications firm BT.

----------

JD Sports Fashion said it has seen further positive trading in all regions through May, with overall growth in organic sales at constant exchange rates in the month of around 8%. In the first three months of the year, organic sales growth at constant exchange rates was more than 15%. The moderation in growth was in line with expectations and reflected tougher comparatives in the year prior as the supply chain normalised and the availability of product improved, the retailer explained. It noted that there has been some softening of trade in North America, which partially offset positive trends in the UK, Europe and the Asia Pacific region. JD Sports nonetheless said profit before tax and adjusting items in the financial year ending February 3, 2024 will be in line with market consensus, which it put at GBP1.04 billion. This would be up from GBP991.4 million in financial 2023.

----------

GSK announced that the US Food & Drug Administration has granted a fast track designation for its Neisseria gonorrhoeae investigational vaccine for the prevention of the sexually transmitted infection gonorrhoea. The vaccine candidate is currently in an ongoing phase II trial and aims to demonstrate proof of concept by assessing the efficacy of the vaccine in healthy adults, 18 to 50 years of age, considered at risk of gonorrhoea. Fast track designation is intended to facilitate the development and expedite the review of potentially important new drugs and vaccines to treat or prevent serious conditions with unmet medical needs. Gonorrhoea is the second most prevalent bacterial sexually transmitted infection worldwide, the pharmaceutical company explained.

----------

COMPANIES - FTSE 250

----------

Consumer good firms PZ Cussons said it expects revenue in the financial year that ended May 31 to be around GBP655 million and adjusted pretax profit to be at least GBP70 million. The firm said this reflected like-for-like revenue growth of 6.7% in the final quarter, as well as a particularly strong performance in Africa. In Africa, PZ Cussons also welcomed the recent policy announced by the Central Bank of Nigeria to "liberalise" the foreign exchange regime, which the firm said is "highly likely" to remove some of the cash challenges faced by multi-national companies but has also resulted in a devaluation of the nation's currency. However, PZ Cussons expects no impact on its full-year results as a result of this devaluation but noted it will impact its future performance in financial 2024.

----------

Telecom Plus reported an "outstanding" year, with sharp rises in both annual profit and revenue. The multi-utilities firm posted a pretax profit of GBP85.5 million, up sharply from GBP47.2 million the year prior, and revenue of GBP2.5 billion, more than double the GBP967.4 million achieved the previous year. Telecom Plus said the "record" revenue and profit reflected the strong double-digit growth in customer and service numbers and significant rises in the Ofgem energy price cap over the period. The firm proposed a final dividend of 46 pence, up from 30p the year prior. This would bring its total payout for the year to 80p, up from 57p last year.

----------

Diversified Energy set out details for its planned share buyback programme. It will buy back up to GBP97.4 billion in shares. The programme will expire on June 30, 2024 or at the company's 2024 annual general meeting. The US-focused energy company said it believes the repurchases will enhance earnings per share and would be in the best interest of its shareholders. The maximum numbers of share repurchased will be 97.4 million.

----------

OTHER COMPANIES

----------

Wise reported a significant surge in annual profit in the financial year that ended March 31, supported by solid growth in active customers. The money transfer firm reported pretax profit of GBP146.5 million, multiplied from GBP43.9 million the year prior. Revenue in the year jumped 51% to GBP846.1 million from GBP559.9 million. This came as the company upped its active customer number by 34% year-on-year to around 10 million. It noted this customer growth led to a 37% year-on-year increase in volumes to GBP104.5 billion. The growth in customers and resulting volumes were the main driver behind the 42% increase in cross-border transaction revenue to GBP679.5 million, it added. Looking forward, Wise said it expects active customer growth to be the primary driver of income growth in financial 2024. It expects active customer growth to be between 28% and 33% in financial 2024.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.